Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chicken toll-like receptors and their role in immunity

  • T.R. KANNAKI, M.R. REDDY, M. SHANMUGAM, P.C. VERMA, R.P. SHARMA
  • Journal:
    World's Poultry Science Journal / Volume 66 / Issue 4 / December 2010
    Published online by Cambridge University Press:
    17 December 2010, pp. 727-738
    Print publication:
    December 2010

  • Toll-like receptors (TLRs) are a group of highly conserved molecules that initiate innate immune responses to pathogens by recognizing structural motifs. In response to pathogen associated molecular patterns (PAMPs), TLRs induce the production of reactive oxygen and nitrogen intermediates (ROI and RNI), inflammatory cytokines and up regulate the expression of co-stimulatory molecules, subsequently initiating adaptive immunity. Ten chicken TLR genes have been identified and their association with various diseases has been ascertained. This review concerns chicken toll-like receptors, their structure, expression, signalling, and their role in innate and adaptive immunity and disease resistance. It is concluded that TLR genes could be used as molecular markers for genetic selection for the improvement of disease resistance and TLR agonists as potential adjuvants in future vaccines.